Valuation: CVRx, Inc.

Market Cap 130M 114M 106M 97.51M 183M 12.57B 186M 1.27B 495M 6.13B 487M 477M 21.26B P/E 2026 *
-2.49x
P/E 2027 * -2.58x
Enterprise Value 155M 137M 127M 117M 219M 15.04B 223M 1.52B 592M 7.33B 583M 570M 25.45B EV / Sales 2026 *
2.38x
EV / Sales 2027 * 2.6x
Free-Float
85.82%
Yield 2026 *
-
Yield 2027 * -
1 day-2.25%
1 week-1.74%
Current month-6.14%
1 month-6.41%
3 months-37.51%
6 months-34.18%
Current year-32.05%
1 week 4.64
Extreme 4.64
5.1
1 month 4.64
Extreme 4.64
6.01
Current year 4.37
Extreme 4.3701
9.84
1 year 4.37
Extreme 4.3701
11.3
3 years 4.3
Extreme 4.2993
33.14
5 years 4.3
Extreme 4.2993
33.14
10 years 4.3
Extreme 4.2993
33.14
Manager TitleAgeSince
Chief Executive Officer 60 11/02/2024
Director of Finance/CFO 43 30/09/2020
Chief Operating Officer 57 10/08/2025
Director TitleAgeSince
Director/Board Member 61 30/09/2008
Director/Board Member 57 30/06/2020
Director/Board Member 52 30/06/2020
Date Insider Type Main position Quantity % Market Cap.
01/06/26 Free

Director

19,902 0.0750%
01/06/26 Free

Director

19,902 0.0750%
01/06/26
Vensana Capital Management LLC
OtherCompany 0 0%
Change 5-day change 1-year change 3-year change Capi.($)
-2.25%-1.74%-41.09%-71.30% 130M
+0.27%+0.18%+38.54%+5.36% 12.5B
+0.52%-0.95%+14.98%+20.01% 6.39B
-0.53%-2.57%+45.33%+20.46% 5.5B
+3.28%-0.18% - - 4.59B
-3.39%-1.19%-29.45%+18.83% 4.47B
-2.85%-4.45%-23.96%-24.19% 4.03B
-7.88%+14.38%+45.22%-52.49% 2.32B
-0.34%-4.23%-12.63%+204.03% 1.71B
+0.33%+0.33%+56.68%-2.86% 1.55B
Average -1.33%+0.42%+10.40%+13.09% 4.32B
Weighted average by Cap. -0.63%+1.01%+19.79%+13.16%

Financials

2026 *2027 *
Net sales 65.28M 57.42M 53.34M 49.06M 92M 6.32B 93.65M 638M 249M 3.08B 245M 240M 10.7B 76.18M 67M 62.24M 57.24M 107M 7.38B 109M 744M 290M 3.6B 286M 280M 12.48B
Net income -52.82M -46.46M -43.16M -39.69M -74.44M -5.12B -75.77M -516M -201M -2.49B -198M -194M -8.66B -52.14M -45.86M -42.6M -39.18M -73.48M -5.05B -74.8M -509M -199M -2.46B -196M -192M -8.54B
Net Debt 25.51M 22.44M 20.84M 19.17M 35.95M 2.47B 36.6M 249M 97.22M 1.21B 95.78M 93.71M 4.18B 68.44M 60.19M 55.92M 51.43M 96.45M 6.63B 98.18M 669M 261M 3.23B 257M 251M 11.22B
Logo CVRx, Inc.
CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programmed by a wireless clinician-controlled programmer that communicates with the IPG.
Employees
223
Date Price Change Volume
24/07/26 US$4.825 -1.34% 64,133
23/07/26 US$4.890 -3.93% 187,457
22/07/26 US$5.090 +2.41% 102,768
21/07/26 US$4.970 +4.19% 311,159
20/07/26 US$4.770 -2.85% 347,482
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
4.890USD
Average target price
11.17USD
Spread / Average Target
+128.36%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CVRX Stock